Analyst Ratings for Coherus Biosciences (CHRS) [Buys]
CHRS Rating Summary
CHRS Price Target Summary
- Highest: $14.00 (Citi)
- Lowest: $7.00 (Barclays)
- Average: $8.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.75 (+314.7%)
* Over Last 12-Mos
Rating Score: 7.5 / 10 Percentile Rank: 80%
Rating Score: 7.5 / 10 Percentile Rank: 80%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/17/2023 | Baird » Updated 1/23/2024 |
Colleen Kusy | New Coverage | Outperform (N/A) |
9.00 (11.00) |
1.80 (2.11) |
17.22% | Details |
7/24/2023 | Citi » Updated 10/30/2023 |
Yigal Nochomovitz | New Coverage | Buy (N/A) |
14.00 (13.00) |
4.17 (2.11) |
-49.4% | Details |